The first phase of Fujifilm Biotechnologies’ $3.2-billion large-scale cell culture biopharmaceutical manufacturing plant in North Carolina is scheduled to begin operating this year.

Louisiana accused pharmaceutical giant CVS of using its dominant market position to abuse customer information, drive up drug costs and unfairly undermine independent pharmacies.

Apple has quietly updated its Transparency Report page with data from January through June 2024 regarding government user data rquests.

Apple has published the full details of the App Store Transparency Report on its website, including an in-depth supplemental CSV file with specific information on every piece of data.

Indian drugmaker Mankind Pharma reported a fourth-quarter profit that beat analysts' estimates on Wednesday, driven by strong domestic demand for its drugs to treat long-term illnesses.

Market failure is driving much of the pharmaceutical pricing and availability problem, according to Becerra, who called on Congress to intervene to make the industry more transparent.

Innocan Pharma intends to continue expanding its intellectual property portfolio in other key territories worldwide, reinforcing its leadership in cannabidiol-based wellness innovation.

Global drugmakers’ stocks dropped across the board today after U.S. President Donald Trump reiterated plans for a “major” tariff on pharmaceutical imports, threatening an interwoven supply ...

Through ‘radical transparency,’ Kennedy can finally rein in Big Pharma by Brandon Novick, opinion contributor - 03/06/25 9:00 AM ET ...

Ascendis Pharma plans to utilize $25 million for share repurchases and net settlement of RSUs, preserving 200,000 ADSs.

In today's Pharmalittle roundup: pharma donations to lawmakers, PBM transparency in New York, and more.

During her first briefing, White House press secretary Karoline Leavitt pledged to provide the truth from the podium while advocating for President Trump's policies, emphasizing transparency and ...